[December 20, 2013]

TOMI™ Extends Its Collaboration with SixLog Corporation and Receives Purchase Order for 10 SteraMist™ Environment Units

TOMI Environmental Solutions, Inc. (OTCQB: TOMZ), a global bacteria decontamination and infectious disease control company with both end user and service provider clients, announced today a collaboration with SixLog Corporation, a worldwide biological decontamination and sterilization services company using SteraMist™ Environment Units.

SixLog Corporation, a rapidly growing sterilization division of parent company Astro Pak Corporation, recently placed an order for 10 SteraMist^™ Environment Units. SixLog is registered and licensed by the California EPA Department of Pesticide Regulation. SixLog and Astro Pak's Chief Financial Officer, Ken Carroll, stated, "Having researched potential technologies, we have extended our collaboration with TOMI's novel SteraMist^™ technology powered by Binary Ionization Technology® to be used by our service teams with our overall goal to help safeguard the environment in the life and health sciences companies that contract with SixLog."

Dr. Halden Shane, TOMI's Chief Executive Officer, stated, "This purchase order from a repeat customer is a great way to move into the new year and accelerate our expansion strategy so as to allow us to build more shareholder value."

™ technology is a decontamination system that applies cold plasma activation to a low percentage hydrogen peroxide-based aerosol, which then produces a Reactive Oxygen Species ("ROS") mist that deactivates organic compounds and quickly inactivates viruses and bacteria including bacterial spores (C. diff) as well as mold spores, other fungi and yeast, both in the air and on surfaces. SteraMist^™ leaves no residue or noxious fumes, provides fast-acting, broad-spectrum decontamination and is environmentally friendly and is safe for delicate medical equipment and computers.

About TOMI™ Environmental Solutions, Inc.

TOMI^™ Environmental Solutions, Inc. (OTCQB: TOMZ) is a global bacteria decontamination and infectious disease control company, providing green energy-efficient environmental solutions for indoor surface decontamination through manufacturing, sales and licensing of our premier platform of Hydrogen Peroxide aerosols, products and technologies.

TOMI^™'s products are designed to service a broad spectrum of commercial structures including medical facilities, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, and athletic facilities. TOMI^™'s products and services have also been used in single-family homes and multi-unit residences.

TOMI™ also develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, The Restoration Industry Association and the Indoor Air Quality Association.

For additional product information, visit www.tomiesinc.com or contact us at [email protected].

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.

[ Back To TMCnet.com's Homepage ]